Ad van Bodegraven
0000-0003-2636-303X
Zuyderland Medisch Centrum Sittard-Geleen
8 papers found
Refreshing results…
Editorial: IBD cost evolution – transitioning from compensating lost productivity to escalating medication expenses
Abdominal pain in patients with inflammatory bowel disease in remission: A prospective study on contributing factors
Editorial: thiopurines in the multidrug era—time to rescue our memories over half a century of experience. Authors' reply
Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease
Editorial: assessment of inflammatory bowel disease—a picture is worth a thousand words
Editorial: the most commonly used IBD indices still fail to represent real life and subjective patient experience
Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapies
Editorial: nocebo effect and switching to biosimilars
Missing publications? Search for publications with a matching author name.